FDA approves bladder cancer diagnostics

The US Food & Drug Administration has given approval to Israel’s Applied Spectral Imaging for its in-vitro aid that can detect chromosomal aberrations in bladder cancer. The SpotScan GenASIs Scan & Analysis system targets cells based on colour, size and their signals pattern.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.